Women with elevated blood concentrations of two widespread "forever chemicals" may face a significantly heightened risk of developing a particularly aggressive and difficult-to-treat form of breast cancer, according to comprehensive new research published by the National Institutes of Health (NIH), an agency operating under the U.S. Department of Health and Human Services (HHS).
The landmark study successfully identified a troubling connection between estrogen receptor-negative, or ER-negative, breast cancer and two ubiquitous chemical compounds: perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). According to the findings, women who harbored greater concentrations of these specific substances in their bloodstream demonstrated a substantially higher likelihood of developing this specific, severe subtype of the disease. However, the researchers noted an important distinction, finding no clear statistical link between either chemical and overall breast cancer risk when looking at all types of the disease combined.
Both of the implicated substances belong to an expansive family of man-made compounds known as per- and polyfluoroalkyl substances, which are routinely referred to by public health advocates and scientists alike as "forever chemicals." These compounds have been utilized for decades in a vast array of everyday consumer products, ranging from non-stick cookware and water-resistant clothing to stain-resistant fabrics, food packaging, and various industrial applications. They earned their grim moniker because they possess chemical structures that fiercely resist breaking down naturally in the environment. Furthermore, once these substances enter the human body, they can accumulate in various tissues and remain detectable in the bloodstream for many years.
"Women deserve clear answers about how chemicals in their environment may affect their health," said HHS Secretary Robert F. Kennedy, Jr., addressing the implications of the new research. "This NIH study links two forever chemicals to a higher risk of ER-negative breast cancer and demands further investigation. Under President Trump’s leadership, we will pursue the evidence, confront environmental health risks, and give women the information they need to protect their health."
Why This Aggressive Breast Cancer Is Concerning
To fully understand the gravity of the new findings, public health officials emphasize the distinct and dangerous nature of ER-negative breast cancer compared to more commonly diagnosed forms of the disease. While many breast cancers rely on hormones like estrogen to fuel their growth and can therefore be treated with hormone-blocking therapies, ER-negative tumor cells entirely lack the necessary receptors that allow estrogen to stimulate their expansion. Consequently, these particular cancers are frequently much more aggressive, grow and spread at a faster rate, and generally result in poorer clinical outcomes and survival rates than tumors that respond positively to hormonal therapies.
Despite the severe health implications associated with ER-negative breast cancer, the medical and scientific communities still possess relatively little concrete information regarding what triggers the disease or makes an individual more susceptible to developing it. The new research findings suggest that long-term exposure to certain persistent environmental chemicals could represent a critical, previously underappreciated contributing factor in the development of these tumors.
"Our findings, which we confirmed using a meta-analysis of prior research, indicate that certain legacy PFAS, including PFOA and PFOS, are associated with a higher risk of ER-negative breast cancer, a more aggressive tumor type with few known risk factors," explained NIH Stadtman Investigator Alexandra White, Ph.D., who led the rigorous investigation.
The detailed results of the study were officially published in the Journal of Clinical Oncology, bringing widespread peer-reviewed attention to the intersection between environmental toxicology and oncology.
Higher Forever Chemical Levels Linked to Greater Cancer Risk
To investigate the potential connection between these persistent environmental contaminants and subsequent cancer diagnoses, NIH scientists and their multidisciplinary collaborators undertook a meticulous analytical approach. They examined archived blood samples that had been collected from study participants years before any of the women received a cancer diagnosis. By measuring the concentrations of 17 different PFAS chemicals present in these historical blood samples, the researchers were able to draw direct comparisons between earlier chemical exposure levels and subsequent breast cancer outcomes over time.
The resulting data revealed substantial and statistically significant differences specifically regarding PFOA and PFOS. When analyzing the data, researchers found that women who fell into the highest PFOA exposure group experienced a 67% higher rate of ER-negative breast cancer compared to women who recorded the lowest exposure levels. The statistical association proved even stronger when examining PFOS, where the highest exposure group demonstrated a staggering 93% higher rate—nearly doubling the risk observed in the lowest exposure category.
Methodologically, researchers emphasize that these reported percentages represent relative differences in risk between specific population groups rather than the absolute mathematical probability that an individual woman will contract breast cancer in her lifetime. Moreover, the study establishes a compelling epidemiological association rather than definitive proof that the chemical compounds directly cause the cellular transformations leading to the disease.
The comprehensive analysis was made possible by leveraging extensive data gathered from the Sister Study, a major, long-term research initiative spearheaded by the National Institute
of Environmental Health Sciences (NIEHS), a division of the NIH. Conducted between 2003 and 2009, the Sister Study successfully enrolled 50,884 women ranging in age from 35 to 74 from communities across the United States and Puerto Rico.
Crucially, all participants enrolled in the project were completely free of breast cancer at the time of their entry, though every woman had a full or half-sister who had previously been diagnosed with the disease, placing them at an elevated familial risk. For the specific PFAS investigation, researchers narrowed their focus to analyze detailed biological and lifestyle information from 1,609 women who subsequently went on to develop breast cancer, alongside a carefully matched comparison group of 2,269 women who remained cancer-free.
Could Reducing PFAS Exposure Lower Cancer Risk?
Although forever chemicals have earned their reputation due to their stubborn persistence in both the global ecosystem and human biological tissues, researchers emphasize that personal exposure is not entirely unavoidable or immutable. The new findings could eventually pave the way toward identifying novel, actionable strategies designed to mitigate the risk of developing aggressive breast cancer variants.
"These findings matter for women’s health broadly," noted the study’s first author, Che-Jung Chang, Ph.D., who previously served as an NIH research fellow and currently works as a researcher at DLH, a prominent scientific research organization. "Although PFAS are persistent in the environment and in our bodies, exposure to them is still potentially modifiable, meaning people can take steps to reduce their exposure, and these findings could open new avenues for prevention."
Beyond quantifying the statistical risk, the research team is actively interested in unraveling the underlying biological mechanisms through which these synthetic chemicals might influence cancer development. Because the strongest statistical associations appeared specifically in tumors lacking estrogen receptors, the findings strongly imply that PFAS could operate through biological pathways entirely unrelated to traditional hormonal signaling systems.
Potential biological explanations under consideration by toxicologists include subtle disruptions in gene activity, alterations in cellular signaling, or systematic suppressions and modifications within the human immune system. However, because the study was observational and did not directly investigate these intricate microscopic mechanisms, their exact role in tumor promotion remains a subject for ongoing scientific inquiry.
Newer Forever Chemicals Raise Unanswered Questions
In response to mounting environmental and health concerns over the past couple of decades, both PFOA and PFOS have largely been phased out of active commercial manufacturing within the United States and replaced with alternative chemical formulations. Despite these regulatory shifts and industry phase-outs, measurable residual amounts of both legacy substances remain stubbornly present in the bloodstreams of the vast majority of the population. Their extreme chemical persistence ensures that historical and ongoing background exposure to these older compounds continues to represent a significant public health concern.
Looking ahead, the study’s authors assert that future scientific investigations should concentrate heavily on populations experiencing disproportionately greater PFAS exposure, as well as demographic groups that historically suffer from higher rates of ER-negative breast cancer. Conducting targeted research within these vulnerable populations could help clarify the exact strength of the observed associations and determine whether specific communities face compounded risks.
Simultaneously, scientists face an urgent imperative to determine whether the newer generations of chemical compounds introduced as direct replacements for PFOA and PFOS carry similar or distinct long-term health hazards.
"More research is needed, particularly evaluating the risk of breast cancer associated with newer replacement PFAS chemicals," White concluded, highlighting the evolving nature of chemical safety assessments.
The newly published findings contribute substantially to the growing body of scientific literature questioning the long-term health ramifications of forever chemicals. By shining a light on environmental risk factors, the study underscores the critical importance of understanding how anthropogenic chemical exposures may silently contribute to the pathogenesis of aggressive and challenging forms of breast cancer.
Financial and structural support for the research was provided through dedicated research grants issued by the NIEHS, including grants Z01ES044005, Z1AES103332, and R01ES032831.